Karachi: Citi Pharma Ltd, a prominent player in the pharmaceuticals sector, has disclosed a significant transaction involving its executive leadership. According to the company’s notification dated January 20, 2026, Rizwan Ahmad, the Executive Director, has executed a noteworthy acquisition of shares.

On January 19, 2026, Rizwan Ahmad purchased 2.00 million shares of Citi Pharma Ltd. The transaction was conducted through the Central Depository Company (CDC) in the ready market. The cumulative number of shares now held by Mr. Ahmad corresponds to a cumulative percentage of 20.90% of the company’s shares.

According to information available from the Pakistan Stock Exchange (PSX), this acquisition represents a significant move within the market, reflecting strategic decisions at the executive level of Citi Pharma Ltd. The acquisition further consolidates Mr. Ahmad’s position as a substantial shareholder in the company.

The disclosure was made in compliance with the PSX Regulation S.O.S., ensuring transparency in the dealings of key personnel within the organization. The market continues to observe such transactions closely, given their potential impact on the company’s strategic direction and investor confidence.